Home/Filings/4/0001140361-24-037708
4//SEC Filing

Eastling Thomas Wilson 4

Accession 0001140361-24-037708

CIK 0001124105other

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 8:58 PM ET

Size

5.4 KB

Accession

0001140361-24-037708

Insider Transaction Report

Form 4
Period: 2024-08-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-08-14+26,00026,000 total
    Exercise: $9.98Exp: 2034-08-14Common Stock (26,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through August 14, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Issuer

GYRE THERAPEUTICS, INC.

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001958487

Filing Metadata

Form type
4
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 8:58 PM ET
Size
5.4 KB